Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.
A recent study found one in five people with HIV should be assessed for fatty liver, and 1 in 10 should be referred to a liver specialist.
This finding may reflect higher rates of sexually transmitted infections such as HPV and hep B as well as lifestyle factors.
Researchers analyzed more than 350 studies to estimate the prevalence of hepatitis B among people with HIV around the world.
Researchers have called for revised treatment guidelines to address the higher risk of fracture in the HIV population.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
The latest revision recognizes the importance of treatment as prevention.
Experts are not certain what this latest trend signifies for the trajectory of the opioid use disorder epidemic, however.
Health officials with Goshen Hospital in Indiana called the risk of infection “extremely low.”
New cases of all three viruses have declined in the city over the past decade.
Here’s the only good thing about the outbreak.
TellYourPartner.org allows you to anonymously relay via text or email that you might have passed on a sexually transmitted infection.
Sci-B-Vac may offer more protection for older people and those with a weaker immune system.
This finding from a study of people switching from TDF to TAF for HIV treatment may also have implications for those on PrEP.
Judge’s ruling may pave the way for opening the nation’s first supervised overdose prevention facility.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.